Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Modern Wealth Management LLC

Modern Wealth Management LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,036 shares of the medical equipment provider’s stock after acquiring an additional 136 shares during the quarter. Modern Wealth Management LLC’s holdings in Intuitive Surgical were worth $541,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on ISRG. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Robert W. Baird dropped their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $507.90 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm’s 50-day moving average is $558.29 and its 200-day moving average is $532.25. The company has a market cap of $180.90 billion, a P/E ratio of 79.24, a PEG ratio of 5.85 and a beta of 1.43.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.